Two forms of porphyria cutanea tarda, a disorder which results from decreased hepatic uroporphyrinogen decarboxylase activity, can be distinguished by determining the tissue distribution of the enzyme defect. In one form, which is inherited as an autosomal dominant disorder, the defect is present in all tissues; in the other, which occurs sporadically, the enzyme defect cannot be detected in extrahepatic tissues. It has been suggested that most cases of the latter form may be associated with a genetic defect restricted to the liver (Kushner, 1982) . If this is so, the existence of tissuespecific isoenzymes might be expected. Differences between the M , values of the enzymes purified from human erythrocytes (De Verneuil et al., 1983; Elderetal., 1983) and bovine liver (Straka & Kushner, 1983 ) have been reported. We now describe the use of an antiserum to human erythrocyte uroporphyrinogen decarboxylase to compare VOl. 12 BIOCHEMICAL SOCIETY TRANSACTIONS the properties of the enzyme in human erythrocytes and liver.
Whole blood, anticoagulated with EDTA, was haemolysed by freeze-thawing three times. Wedge biopsies of human liver, each obtained at laparotomy under general anaesthesia as part of an essential diagnostic procedure, were homogenized (10-20% w/v) in 0.1 M-K,HPO,! KH,PO, buffer (pH 6.8)/0.1 mM-EDTA f 1 .OmM-phenylmethylsulphonyl fluoride and centrifuged at 1 5000ga,, for 5 min to obtain a supernatant fraction. Haemolysates and supernatant fractions were stored at -70°C.
The antiserum to human erythrocyte uroporphyrinogen decarboxylase was raised in a rabbit (antiserum 11; Elder et al., 1983). Solid-phase antibody was prepared by reacting an immunoglobulin G fraction from this antiserum with a diazonium salt of reprecipitated cellulose. Solid-phase antibody was incubated with tissue preparations for 2h at room temperature followed by 16h at 4°C. Solid-phase antibody-enzyme conjugate was recovered by centrifugation followed by washing the pellet three times with homogenization buffer. Electroimmunoassay was carried out in 1 % agarose/0.025 M-sodium barbital/HCl buffer (pH 8.6) gel containing antiserum (0.5pl/ml) and Iz5I-labelled immunoglobulin G (6 x 103c.p.m. ml; equivalent to 0.16~1 of antiserum/ml). Rockets were visualized by autoradiography. Calibration graphs were prepared from dilutions of haemolysate or liver supernatant. Uroporphyrinogen decarboxylase activity was measured using pentacarboxyl porphyrinogen 111 as substrate (Elder et al., 1983) .
Solid-phase antibody adsorbed greater than 95% of the uroporphyrinogen decarboxylase activity from haemolysates and liver supernatants. Approximately the same amount of solid-phase antibody was required to bind equivalent amounts of enzyme activity from each tissue. Enzyme bound to solid-phase antibody retained activity (recoveries greater than 77%). Conjugates prepared from haemolysate and liver supernatant had similar substrate affinities for pentacarboxyl porphyrinogen I11 (apparent K,, values 3 . 7~~ and 4.5pM respectively). Thermal inactivation curves for the conjugates were also similar. After incubation at 60°C for 20min, 48% (liver) and 45% (erythrocytes) of the initial activity remained. After 60min, these values had fallen to 26% and 23% respectively.
Electroimmunoassay of haemolysate, liver supernatants and mixtures of these tissues gave single, well-defined rockets. For haemolysates and liver supernatants from two subjects, the ratio of enzyme activity to the concentration of immunoreactive enzyme, as measured by electroimmunoassay, was similar (7.0k0.9 for liver supernatant; 6.8 f0.3 for haemolysate), indicating that enzyme from liver and erythrocyte has the same specific activity. Inclusion of phenylmethylsulphonyl fluoride in the homogenization medium did not alter the specific activity of the hepatic enzyme.
Previous immunochemical studies suggested that the uroporphyrinogen decarboxylases from human liver and erythrocytes are very similar but not identical (Elder et al.,  1983 ). The differences were attributed to post-translational modification of enzyme structure by proteolysis or oxidation of thiol groups. Using a solid-phase antibody, prepared from the antiserum used in our previous studies, together with freshly prepared liver supernatants, we have bljen unable to demonstrate any significant differences between uroporphyrinogen decarboxylase from human erythrocytes and liver with respect to immunoreactivity, specific activity, substrate affinity and heat stability. These findings provide additional evidence against the existence of tissuespecific isoenzymes of human uroporphyrinogen decarboxylase specified by independent genomic sequences.
